Review
doi: 10.1016/j.biotechadv.2012.02.006. Epub 2012 Feb 15.The current state of GMO governance: are we ready for GM animals?
Affiliations
- PMID:22361646
- DOI: 10.1016/j.biotechadv.2012.02.006
Item in Clipboard
Review
The current state of GMO governance: are we ready for GM animals?
Núria Vàzquez-Salat et al. Biotechnol Adv.2012 Nov-Dec.
Display options
Format
Display options
Format
Abstract
Given the history of GMO conflict and debate, the GM animal future is dependent on the response of the regulatory landscape and its associated range of interest groups at national, regional and international levels. Focusing on the EU and the USA, this article examines the likely form of that multi-level response, the increased role of cultural values, the contribution of new and existing interest groups and the consequent implications for the commercialization of both green and red GM animal biotechnology.
Copyright © 2012. Published by Elsevier Inc.
Similar articles
- The EU regulatory framework on genetically modified organisms (GMOs).Bruetschy C.Bruetschy C.Transgenic Res. 2019 Aug;28(Suppl 2):169-174. doi: 10.1007/s11248-019-00149-y.Transgenic Res. 2019.PMID:31321701
- Genes sans frontiéres.MacKenzie D.MacKenzie D.New Sci. 1997 Mar 1;153(2071):50.New Sci. 1997.PMID:11656629No abstract available.
- GM foods debate needs a recipe for restoring trust.[No authors listed][No authors listed]Nature. 1999 Apr 22;398(6729):639. doi: 10.1038/19336.Nature. 1999.PMID:10227273No abstract available.
- Public health issues related with the consumption of food obtained from genetically modified organisms.Paparini A, Romano-Spica V.Paparini A, et al.Biotechnol Annu Rev. 2004;10:85-122. doi: 10.1016/S1387-2656(04)10004-5.Biotechnol Annu Rev. 2004.PMID:15504704Review.
- Options to Reform the European Union Legislation on GMOs: Risk Governance.Eriksson D, Custers R, Edvardsson Björnberg K, Hansson SO, Purnhagen K, Qaim M, Romeis J, Schiemann J, Schleissing S, Tosun J, Visser RGF.Eriksson D, et al.Trends Biotechnol. 2020 Apr;38(4):349-351. doi: 10.1016/j.tibtech.2019.12.016. Epub 2020 Feb 12.Trends Biotechnol. 2020.PMID:32171418Review.
Cited by
- Optimization of native biocontrol agents, with parasitoids of the invasive pestDrosophila suzukii as an example.Kruitwagen A, Beukeboom LW, Wertheim B.Kruitwagen A, et al.Evol Appl. 2018 Jun 14;11(9):1473-1497. doi: 10.1111/eva.12648. eCollection 2018 Oct.Evol Appl. 2018.PMID:30344621Free PMC article.Review.
- Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.Legastelois I, Buffin S, Peubez I, Mignon C, Sodoyer R, Werle B.Legastelois I, et al.Hum Vaccin Immunother. 2017 Apr 3;13(4):947-961. doi: 10.1080/21645515.2016.1260795. Epub 2016 Dec 1.Hum Vaccin Immunother. 2017.PMID:27905833Free PMC article.Review.
- Will GM animals follow the GM plant fate?Vàzquez-Salat N, Houdebine LM.Vàzquez-Salat N, et al.Transgenic Res. 2013 Feb;22(1):5-13. doi: 10.1007/s11248-012-9648-5. Epub 2012 Sep 18.Transgenic Res. 2013.PMID:22987246
- Use of transgenic animals in biotechnology: prospects and problems.Maksimenko OG, Deykin AV, Khodarovich YM, Georgiev PG.Maksimenko OG, et al.Acta Naturae. 2013 Jan;5(1):33-46.Acta Naturae. 2013.PMID:23556129Free PMC article.
- Novel GM animal technologies and their governance.Bruce A, Castle D, Gibbs C, Tait J, Whitelaw CB.Bruce A, et al.Transgenic Res. 2013 Aug;22(4):681-95. doi: 10.1007/s11248-013-9724-5. Epub 2013 Jun 19.Transgenic Res. 2013.PMID:23780762Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources